Why is Trump suing the Wall Street Journal?
What impact will the GENIUS Act have on crypto?
How did Chevron win its $53B Hess deal?
Why is Netflix canceling Stephen Colbert's show?
What caused the S&P 500 to dip recently?
How are tariffs affecting US trade with Europe?
Why is Meta refusing EU AI regulations?
Sarepta shares plunge 30% as future of its gene therapy appears at risk
cnbc.com/2025/07/18/sarepta-stock-falls-on-fda-gene-therapy-elevidys-comment.html
Shares of Sarepta Therapeutics plunged more than 30% on Friday as the future of its approved gene therapy treatment appeared at risk.
The Food and Drug Administration will request that the company voluntarily stop all shipments of the treatment, Elevidys, a person familiar with the…
This story appeared on cnbc.com, 2025-07-18 17:54:14.305000.